[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC]

Pathol Biol (Paris). 2014 Aug;62(4):204-8. doi: 10.1016/j.patbio.2014.05.012. Epub 2014 Jul 10.
[Article in French]

Abstract

Autologous hematopoietic stem cell transplantation is a valid alternative to immunosuppressive treatment in patients with auto-immune disease; however, the role of this approach remains subject to debate. In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) set up its fourth annual series of workshops which brought together practitioners from all of its member centers. These workshops took place in September 2013 in Lille. In this article we give an overview regarding the indications of autologous stem cell transplantation in auto-immune diseases as well as recommendations regarding post-transplant follow-up of patients.

Keywords: Auto-immune disease; Autogreffe; Autologous stem cell transplantation; Indications; Maladies auto-immunes.

Publication types

  • English Abstract
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases / surgery*
  • France
  • Humans
  • Immunosuppressive Agents
  • Postoperative Care
  • Stem Cell Transplantation / adverse effects
  • Stem Cell Transplantation / methods*
  • Stem Cell Transplantation / standards
  • Transplantation, Autologous / adverse effects
  • Transplantation, Autologous / methods*
  • Transplantation, Autologous / standards

Substances

  • Immunosuppressive Agents